Eminence Capital’s LivaNova LIVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,737,277
Closed -$96.5M 72
2022
Q4
$96.5M Sell
1,737,277
-352,268
-17% -$18M 1.79% 22
2022
Q3
$106M Buy
2,089,545
+190,613
+10% +$11.3M 2.22% 11
2022
Q2
$119M Sell
1,898,932
-49,215
-3% -$3.48M 2.36% 9
2022
Q1
$159M Buy
1,948,147
+122,470
+7% +$9.52M 1.81% 8
2021
Q4
$160M Buy
1,825,677
+74,658
+4% +$6.23M 1.52% 18
2021
Q3
$139M Buy
1,751,019
+97,723
+6% +$8.03M 1.87% 24
2021
Q2
$139M Buy
1,653,296
+260,172
+19% +$21.4M 1.71% 26
2021
Q1
$103M Buy
+1,393,124
New +$99.4M 1.27% 38

Other funds holding LIVN

Eminence Capital's LIVN Position: Q1 2023 in Review

Eminence Capital sold out of LivaNova (LIVN) in Q1 2023, closing a stake of 1,737,277 shares — an estimated $96.5M sold.

Eminence Capital first reported a position in LIVN in Q1 2021 and held it in 8 quarters. The position peaked at $160M in Q4 2021. 211 funds tracked by Wall St. Rank hold LIVN as of Q1 2023.

  • Eminence Capital reported no remaining LivaNova position as of Q1 2023 after selling out during the quarter.
  • Eminence Capital sold 1,737,277 LivaNova shares in Q1 2023, an estimated $96.5M.
  • Eminence Capital first reported a position in LivaNova in Q1 2021 and held it in 8 quarters.
  • Eminence Capital's LivaNova position peaked at $160M in Q4 2021.
  • 211 funds tracked by Wall St. Rank held LivaNova as of Q1 2023.

Based on Eminence Capital's 13F filing for Q1 2023, filed 15 May 2023.